| Popis: |
Research that is not appropriately communicated is unlikely to realise its potential public health impact. Although essential, the preparation of a scientific article presenting the trial’s main results is rarely, if ever, sufficient. Communication should start before the trial, continue during it, and persist after it has been completed. Preparation and periodic review of a trial communications action plan is essential. For this, the trial team should start by listing all the potential people and institutions (stakeholders) likely to have an interest in the trial and its results, and to think through what information should be provided to each of them, in what format, and when. Specific stakeholders will include trial participants and study communities, the trial sponsor and funder, policy makers, programme managers, and other researchers, and communication channels may include meetings, phone calls, the internet, newsletters, formal reports, policy briefs, radio, TV, and videos. |
